Melphalan in Patients With Neoplastic Meningitis - Contacts and Locations

Home

Melphalan in Patients With Neoplastic Meningitis

This study is ongoing, but not recruiting participants.

Study NCT00002750. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00002750

Locations


United States, North Carolina
	Duke Comprehensive Cancer Center
	Durham, North Carolina, United States, 27710

Sponsors and Collaborators

Duke University

Investigators


Study Chair:	Henry S. Friedman, MD	Duke University